Berkeley, CA, United States of America

Katherine Rendahl

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2005-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Katherine Rendahl: A Pioneer in Antibody Drug Conjugates

Introduction

Katherine Rendahl is a prominent inventor based in Berkeley, California, recognized for her significant contributions to the field of biopharmaceuticals. With a total of three patents to her name, Katherine has focused her research on innovative treatments for cancer, particularly through the development of antibody drug conjugates that leverage the body's immune system.

Latest Patents

Two of Katherine Rendahl's latest patents are centered around antibody drug conjugates. These applications disclose anti-P-cadherin antibodies and their antigen binding fragments, detailing the methods for treating cancer using these antibodies. The inventions also encompass the creation and utilization of antibodies as diagnostic reagents, offering a dual approach in both therapeutic and diagnostic settings. The inventive methodologies for manufacturing these antibody drug conjugates highlight her expertise and commitment to advancing cancer treatment.

Career Highlights

Katherine has built her professional journey by working with reputable organizations in the pharmaceutical and academic sectors. Notably, she has been affiliated with Novartis AG, a leading global healthcare company, and the University of California, where she has contributed to numerous research initiatives. Her work reflects a deep commitment to innovative science and the pursuit of effective therapies.

Collaborations

Throughout her career, Katherine Rendahl has collaborated with esteemed individuals in her field, including Tinya Abrams and Steven Bruce Cohen. These partnerships have fostered a rich exchange of ideas and expertise, bolstering her research and expanding the potential impact of her inventions.

Conclusion

Katherine Rendahl exemplifies the spirit of innovation within the biotech industry. Her dedication to developing groundbreaking approaches in cancer treatment through antibody drug conjugates marks her as a significant contributor to medical science. With her impactful patents and collaborative spirit, Katherine continues to shape the future of therapeutic possibilities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…